⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 19, 2020The American Journal of Gastroenterology

Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID

Constance Chapuis-Biron Julien Kirchgesner Benjamin Pariente Yoram Bouhnik Aurélien Amiot S Viennot Mélanie Serrero Mathurin Fuméry Matthieu Allez Laurent Siproudhis Anthony Buisson Guillaume Pineton de Chambrun Véred Abitbol Stéphane Nancey Ludovic Caillo Laurianne Plastaras Guillaume Savoye Elise Chanteloup Marion Simon Nina Dib Sylvie Rajca Morgane Amil Anne-Laure Parmentier Laurent Peyrin–Biroulet Lucine Vuitton Getaid Biolap Study Group

View at Publisher

Ask AI

Bookmark

Share

Abstract

Ustekinumab appears as a potential effective therapeutic option in perianal refractory CD. Further prospective studies are warranted.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chapuis-Biron et al. (2020) studied this question.

synapsesocial.com/papers/69d8ace78c03fbaff8befdd0 https://doi.org/10.14309/ajg.0000000000000810

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's diseaseNarrative Review · 2014 · 425 citations
23rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical ManagementOriginal Research · 2016 · 2,057 citations
3Development of an index to define overall disease severity in IBDOriginal Research · 2016 · 152 citations
4Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel DiseasesPrognostic Study · 2016 · 154 citations
5The comparative analysis of amount of exhaled carbon monoxide as an indicator of smoking among students of selected universities in WroclawOriginal Research · 2013

More related papers

Self‐reported depressive symptoms and suicidal feelings in perianal Crohn’s disease2011
The results of seton drainage combined with anti‐ TNF α therapy for anal fistula in Crohn's disease2014
Treatment of Perianal Fistulizing Crohn's Disease with Infliximab Alone or as an Adjunct to Exam Under Anesthesia with Seton Placement2003

More from The American Journal of Gastroenterology

Duodenal involvement in MUTYH-associated polyposis: findings from an international study and implications for endoscopic surveillance.Tue,
Modern Approach to Reflux Testing: When, Which, and How?Tue,